Holen Sie sich die Stockscreener-App
18.82
2.95%
0.54
Vorhandelsmarkt:
19.45
0.63
+3.35%
Schlusskurs vom Vortag:
$18.28
Offen:
$18.32
24-Stunden-Volumen:
985.55K
Relative Volume:
0.73
Marktkapitalisierung:
$1.08B
Einnahmen:
$322.02M
Nettoeinkommen (Verlust:
$-102.47M
KGV:
-10.29
EPS:
-1.8295
Netto-Cashflow:
$-80.57M
1W Leistung:
+7.48%
1M Leistung:
+1.67%
6M Leistung:
-23.99%
1J Leistung:
-45.62%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$17.52
$19.11
52-Wochen-Spanne:
$16.66
$38.11
Procept Biorobotics Corp Stock (PRCT) Company Profile
Firmenname
Procept Biorobotics Corp
Sektor
Branche
Telefon
(650) 232-9832
Adresse
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
18.82 | 1.08B | 322.02M | -102.47M | -80.57M | -1.8295 |
ABT
Abbott Laboratories
|
102.45 | 177.28B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.63 | 121.04B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
304.40 | 116.76B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.58 | 66.06B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.29 | 50.89B | 6.30B | 1.07B | 1.09B | 1.8406 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-10-07 | Eingeleitet | Barclays | Overweight |
| 2026-08-05 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2026-08-05 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2026-07-28 | Herabstufung | UBS | Buy → Neutral |
| 2026-07-06 | Herabstufung | Truist | Buy → Hold |
| 2026-06-24 | Eingeleitet | Evercore ISI | Outperform |
| 2026-06-11 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2026-03-06 | Eingeleitet | Robert W. Baird | Neutral |
| 2026-02-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2026-02-26 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-12-12 | Eingeleitet | UBS | Buy |
| 2025-12-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-09-02 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-07-09 | Eingeleitet | Stephens | Overweight |
| 2025-07-07 | Eingeleitet | Oppenheimer | Perform |
| 2024-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Eingeleitet | Jefferies | Hold |
| 2023-08-11 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-31 | Eingeleitet | William Blair | Outperform |
| 2022-10-31 | Eingeleitet | BTIG Research | Neutral |
| 2022-10-25 | Eingeleitet | Truist | Buy |
| 2022-09-02 | Eingeleitet | Wells Fargo | Overweight |
| 2022-07-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-10-11 | Eingeleitet | Cowen | Outperform |
| 2021-10-11 | Eingeleitet | Goldman | Neutral |
| 2021-10-11 | Eingeleitet | Guggenheim | Buy |
| 2021-10-11 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Procept Biorobotics Corp Aktie (PRCT) Neueste Nachrichten
A director receives rights to 7,727 shares and options on 12,191 at PROCEPT BioRobotics (PRCT). - Stock Titan
LAWSUIT ALERT: Investors who lost money with PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares should contact the Shareholders Foundation - GlobeNewswire Inc.
Important Notice to Long-Term Shareholders of Doximity, Inc. (NYSE: DOCS); GoDaddy Inc. (NYSE: GDDY); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your Behalf - GlobeNewswire Inc.
Kaplan Fox Continues to Alert Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to a Class Action Deadline on September 22, 2026 - theglobeandmail.com
PRCT Deadline: PRCT Investors with Losses in Excess of $100K Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit - AOL.ca
Deadline Alert: PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
PRCT Deadline: Rosen Law Firm Urges PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Business Wire
Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Seeking Recovery to Contact the Firm Before September 22, 2026 - GlobeNewswire Inc.
INVESTOR DEADLINE: PROCEPT BioRobotics Corporation (PRCT) Investors with Substantial Losses Have Opportunity to Lead the PROCEPT Class Action Lawsuit Before September 22, 2026 - GlobeNewswire Inc.
PROCEPT DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages PROCEPT BioRobotics Corporation Investors to Secure Counsel Before Important September 22 Deadline in Securities Class Action – PRCT - GlobeNewswire Inc.
ROSEN, A LONGSTANDING FIRM, Encourages Doximity, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – DOCS - GlobeNewswire Inc.
DNOW DEADLINE: ROSEN, A LONGSTANDING FIRM, Encourages DNOW Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – DNOW - GlobeNewswire Inc.
WIX.COM DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Wix.com Ltd. Investors to Secure Counsel Before Important September 22 Deadline in Securities Class Action – WIX - GlobeNewswire Inc.
Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to Contact the Firm Before the Lead Plaintiff Deadline on September 22, 2026 - The Globe and Mail
TUESDAY PRCT INVESTOR DEADLINE: PROCEPT BioRobotics Corporation Investors with Substantial Losses Have Opportunity to Lead the PROCEPT Class Action Lawsuit - PR Newswire
Bragar Eagel & Squire, P.C Urges PROCEPT BioRobotics - GlobeNewswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
PROCEPT DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR - GlobeNewswire
PROCEPT DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR - GlobeNewswire
How Discounting Lawsuits At PROCEPT BioRobotics Stock Have Changed Its Investment Story - simplywall.st
PROCEPT DEADLINE: ROSEN, HIGHLY REGARDED TRIAL ATTORNEYS, - GlobeNewswire
PRCT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PROCEPT BioRobotics Corporation Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - PR Newswire
Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm Before Lead Plaintiff Deadline on September 22, 2026 - Barchart.com
PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
PRCT DEADLINE NOTICE: PROCEPT BioRobotics Corporation Investors Encouraged to Contact Kirby McInerney LLP By September 22, 2026 - ACCESS Newswire
PROCEPT BioRobotics Corporation (PRCT) Investors: September 22, 2026 Filing Deadline in Securities Class ActionContact Lieff Cabraser - ACCESS Newswire
PRCT Deadline: PRCT Investors with Losses in Excess of $100K Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit - Laurel Leader-Call
Procept BioRobotics EVP Alaleh Nouri sells $6,223 in PRCT stock By Investing.com - Investing.com Nigeria
Procept BioRobotics EVP Alaleh Nouri sells $6,223 in PRCT stock By Investing.com - Investing.com Australia
Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm to Learn About Their Legal Rights - theglobeandmail.com
Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm to Learn About Their Legal Rights - theglobeandmail.com
Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm to Learn About Their Legal Rights - Barchart.com
PROCEPT BioRobotics CFO Kevin Waters Sells 373 Shares in Tax Withholding Transaction - kalkinemedia.com
PROCEPT BioRobotics EVP Alaleh Nouri Sells 297 Shares for Tax Withholding on RSU Vesting - kalkinemedia.com
Procept BioRobotics EVP Alaleh Nouri sells $6,223 in PRCT stock - investing.com
Procept BioRobotics EVP Alaleh Nouri sells $6,223 in PRCT stock By Investing.com - Investing.com India
Procept BioRobotics EVP Alaleh Nouri sells $6,223 in PRCT stock By Investing.com - Investing.com UK
Procept BioRobotics EVP Alaleh Nouri sells $6,223 in PRCT stock - Investing.com
Tax-withholding share sale for PROCEPT BioRobotics (PRCT) CTO - Stock Titan
Tax-withholding sale trims PROCEPT BioRobotics (PRCT) CFO stake - Stock Titan
Kaplan Fox Class Action Reminder: PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Lead Plaintiff Deadline is September 22, 2026 - NewMediaWire
PRCT 12-DAY DEADLINE ALERT: PROCEPT BioRobotics Corporation Investors Alerted to September 22, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - PR Newswire
DEADLINE ALERT for WIX, PRCT, and PNR: The Law Offices of - GlobeNewswire
PROCEPT BIOROBOTICS CORPORATION INVESTORS WITH LOSSES HAVE - GlobeNewswire
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with SBS Law - GlobeNewswire
PRCT Deadline Alert: SueWallSt Reminds PROCEPT BIOROBOTICS CORPORATION (PRCT) Investors of Securities Class Action Deadline on September 22, 2026 - PR Newswire
Kaplan Fox Class Action Reminder: PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Lead Plaintiff Deadline is September 22, 2026 - The Globe and Mail
Kaplan Fox Class Action Reminder: PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Lead Plaintiff Deadline is September 22, 2026 - FinancialContent
Finanzdaten der Procept Biorobotics Corp-Aktie (PRCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Procept Biorobotics Corp-Aktie (PRCT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Waters Kevin | EVP, CFO |
Sep 09 '26 |
Sale |
20.95 |
373 |
7,815 |
180,355 |
| Templin Barry L | EVP, Chief Technology Officer |
Sep 09 '26 |
Sale |
20.95 |
373 |
7,815 |
94,826 |
| Nouri Alaleh | Officer |
Sep 09 '26 |
Proposed Sale |
20.95 |
297 |
6,223 |
0 |
| Templin Barry L | Officer |
Sep 09 '26 |
Proposed Sale |
20.95 |
373 |
7,816 |
0 |
| Waters Kevin | Officer |
Sep 09 '26 |
Proposed Sale |
20.95 |
373 |
7,816 |
0 |
| Wood Larry L | President, CEO |
Aug 07 '26 |
Buy |
20.85 |
23,900 |
498,315 |
23,900 |
| Nouri Alaleh | EVP, CLO, CORP. SEC. |
Jun 08 '26 |
Sale |
28.48 |
285 |
8,117 |
105,069 |
| Waters Kevin | EVP, CFO |
Jun 08 '26 |
Sale |
28.48 |
357 |
10,167 |
151,201 |
| Templin Barry L | EVP, Chief Technology Officer |
Jun 08 '26 |
Sale |
28.48 |
358 |
10,195 |
68,953 |
| Nouri Alaleh | Officer |
Jun 08 '26 |
Proposed Sale |
28.48 |
285 |
8,117 |
0 |
6.46%
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):